KC
AMGN icon

Kades & Cheifetz’s Amgen AMGN Stock Holding History

Kades & Cheifetz’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$218K Sell
835
-217
-21% -$64.4K 0.11% 99
2024
Q3 		$339K Buy
1,052
+35
+3% +$11.4K 0.19% 75
2024
Q2 		$318K Buy
1,017
+7
+0.7% +$2.06K 0.2% 76
2024
Q1 		$287K Buy
1,010
+201
+25% +$58.8K 0.18% 76
2023
Q4 		$233K Sell
809
-75
-8% -$20.4K 0.17% 76
2023
Q3 		$237K Buy
+884
New +$221K 0.19% 68

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Kades & Cheifetz's AMGN Position: Q4 2024 in Review

Kades & Cheifetz reduced its Amgen (AMGN) stake by 21% in Q4 2024, selling an estimated $64.4K and leaving 835 shares worth $218K. The position accounts for 0.11% of the portfolio, ranked #99.

Kades & Cheifetz first reported a position in AMGN in Q3 2023 and has held it in 6 quarters since. The position peaked at $339K in Q3 2024. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Kades & Cheifetz held 835 shares of Amgen worth $218K as of Q4 2024.
  • Kades & Cheifetz sold 217 Amgen shares in Q4 2024, an estimated $64.4K.
  • Amgen made up 0.11% of Kades & Cheifetz's portfolio in Q4 2024, its #99 holding.
  • Kades & Cheifetz first reported a position in Amgen in Q3 2023 and has held it in 6 quarters since.
  • Kades & Cheifetz's Amgen position peaked at $339K in Q3 2024.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Kades & Cheifetz's 13F filing for Q4 2024, filed 13 Jan 2025.